Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Circular RNAs (circRNAs) are implicated in disease pathogenesis, including human hepatocellular carcinoma (HCC).
• Previous studies indicated elevated expression of hsa_circ_0005075 in HCC, but its functional role remained unelucidated.
• Hepatocellular carcinoma (HCC) is a significant global health concern, necessitating research into novel molecular mechanisms and therapeutic targets.

Purpose of the Study:

• To investigate the functional role of hsa_circ_0005075 in hepatocellular carcinoma (HCC).
• To determine the relationship between hsa_circ_0005075 expression and HCC cell proliferation, migration, and invasion.
• To elucidate the regulatory mechanism of hsa_circ_0005075 involving microRNA-431 (miR-431) in HCC.

Main Methods:

• Quantitative analysis of hsa_circ_0005075 expression in HCC tissues and cell lines.
• Assessment of cell proliferation, migration, and invasion using SMMC-7721 cell models.
• Dual-luciferase reporter assays to evaluate the inhibitory effect of hsa_circ_0005075 on miR-431 transcription.
• RNA interference techniques (silencing) and rescue experiments with miR-431 inhibitors.

Main Results:

• hsa_circ_0005075 expression was significantly upregulated in HCC tissues and cell lines compared to normal controls.
• Overexpression of hsa_circ_0005075 correlated with increased proliferative, migratory, and invasive capabilities of HCC cells.
• hsa_circ_0005075 was found to inhibit the transcriptional activity of miR-431.
• Silencing hsa_circ_0005075 reduced HCC cell proliferation, and these effects were reversed by inhibiting miR-431.

Conclusions:

• hsa_circ_0005075 acts as a tumor promoter in hepatocellular carcinoma (HCC).
• The oncogenic function of hsa_circ_0005075 is mediated through the suppression of miR-431.
• hsa_circ_0005075 represents a potential therapeutic target for HCC treatment.